Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Teva
Argus Health
Federal Trade Commission
UBS
Mallinckrodt

Generated: March 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Filibuvir

« Back to Dashboard

US Patents for Filibuvir

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Filibuvir ➤ Sign Up Methods for the preparation of HCV polymerase inhibitors Pfizer Inc. (New York, NY) ➤ Sign Up
Filibuvir ➤ Sign Up Methods for treating HCV AbbVie Inc. (North Chicago, IL) ➤ Sign Up
Filibuvir ➤ Sign Up Methods for treating HCV AbbVie Inc. (North Chicago, IL) ➤ Sign Up
Filibuvir ➤ Sign Up United States Patent: 8680048   ( 1 ➤ Sign Up
Filibuvir ➤ Sign Up Methods for treating HCV AbbVic Inc. (North Chicago, IL) ➤ Sign Up
Filibuvir ➤ Sign Up Cyclic nucleotide analogs Alios BioPharma, Inc. (South San Francisco, CA) ➤ Sign Up
Filibuvir ➤ Sign Up Methods for treating HCV AbbVie Inc. (North Chicago, IL) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Filibuvir

Drugname Country Document Number Estimated Expiration Related US Patent
Filibuvir Argentina 059114 2025-08-24 ➤ Sign Up
Filibuvir Australia 2006283297 2025-08-24 ➤ Sign Up
Filibuvir Brazil PI0615016 2025-08-24 ➤ Sign Up
Filibuvir Canada 2619077 2025-08-24 ➤ Sign Up
Filibuvir China 101426793 2025-08-24 ➤ Sign Up
Filibuvir China 102336758 2025-08-24 ➤ Sign Up
Filibuvir European Patent Office 1928878 2025-08-24 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Colorcon
US Army
Cantor Fitzgerald
Mallinckrodt
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.